Experiment shows dietary selenium enhances fatty acid profiles in lactating donkeys, suggesting microbiome modulation benefits milk quality.
This study evaluated the effects of dietary selenium (Se) supplementation on lactation performance, milk fatty acid composition, and rectal microbiota and short-chain fatty acids in lactating Dezhou donkeys to determine the optimal dose. Twenty-four lactating Dezhou donkeys (estimated milk yield: 3.60 ± 0.84 kg/d; days in milk: 39.93 ± 7.02 d; body weight: 247.24 ± 26.27 kg; parity: 2.82 ± 0.48) were randomly divided into four groups (n = 6): CON (0 mg Se/kg DM), Se1 (0.15 mg Se/kg DM), Se2 (0.3 mg Se/kg DM), and Se3 (0.5 mg Se/kg DM), and were supplemented with Se yeast in the basal diet. The results showed that plasma Se concentrations increased dose-dependently. The Se2 group significantly increased milk yield, milk component yield, milk protein production efficiency, milk production efficiency, the digestibility of acid detergent fiber and neutral detergent fiber, protein biological value, and nitrogen metabolic rate, as well as the proportions of C18:1c9, C18:2c6, unsaturated fatty acids, monounsaturated fatty acids, polyunsaturated fatty acids, n-3 long-chain polyunsaturated fatty acids, the ratio of unsaturated to saturated fatty acids, the ratio of polyunsaturated to saturated fatty acids (P/S), desirable fatty acids, and (C18:0 + C18:1)/C16:0 in donkey milk, while decreasing the proportion of saturated fatty acids, atherogenicity index, and thrombogenic index. The Se2 group also increased acetate and butyrate in rectal feces, and promoted the growth of beneficial bacteria, including Christensenellaceae R-7 group, Lachnospiraceae XPB1014, and norank_f_Erysipelotrichaceae. In summary, the effects of Se supplementation were dose-dependent: 0.3 mg Se/kg DM improved milk performance and optimized milk fatty acid profiles by improving nutrient digestion and metabolism and modulating rectal bacteria structure, whereas 0.5 mg Se/kg DM showed no lactation benefits (with potential inhibitory effects) despite improving the P/S ratio and reducing the atherogenicity and thrombogenic indices.
No takes yet. Share an insight, caveat, or question.
Meng et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: